2 completed. 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Completed 1 |
Follow Pulmonary Alveolar Proteinosis (PAP): new trials by email Literature Review of Pulmonary Alveolar Proteinosis (PAP) trials Research Report on Pulmonary Alveolar Proteinosis (PAP)
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Macrophages, GM-CSF and MARS Proteinosis Blood collection, Bronchoalveolar lavage fluid collection - Pulmonary Alveolar Proteinosis (PAP), MARS | Completed | Assistance Publique - Hôpitaux de Paris | 20 | 2021-06-07 | 2026-04-03 | |
| Rituximab for Anti-cytokine Autoantibody-Associated Diseases Rituximab - Pulmonary Alveolar Proteinosis (PAP), Severe Mucocutaneous Candidiasis | Phase 1 | Completed | National Institute of Allergy and Infectious Diseases (NIAID) | 7 | 2014-04-29 | 2026-10-26 |
Pulmonary Alveolar Proteinosis (2) · Candidiasis, Chronic Mucocutaneous (1)
Lung Diseases (2) · Respiratory Tract Diseases (2) · Bacterial Infections and Mycoses (1) · Candidiasis (1) · Chronic Disease (1) · Dermatomycoses (1) · Disease Attributes (1) · Infections (1) · Mycoses (1) · Pathologic Processes (1) · Pathological Conditions, Signs and Symptoms (1) · Skin Diseases (1) · Skin Diseases, Infectious (1) · Skin and Connective Tissue Diseases (1)
Blood Specimen Collection (1) · Rituximab (1)
Assistance Publique - Hôpitaux de Paris (1) · National Institute of Allergy and Infectious Diseases (NIAID) (1)
France (1) · United States (1)